Mitochondrial Diseases - 22 Studies Found
Terminated |
: Anesthetic Effects in Mitochondrial Disease : Mitochondrial Disease : 2009-10-21 : Drug: sevoflurane During induction, concentration of inspired sevoflurane will begin at .5%, and slowly |
Completed |
: Glycemic Index in Mitochondrial Disease : Mitochondrial Diseases : 2014-10-21 : Other: test meal low- or high-glycemic index test meal, administered during mixed meal tolerance test |
Recruiting |
: Anesthesia in Patients With Mitochondrial Disease : Mitochondrial Diseases : 2014-01-31 :
|
Recruiting |
: Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease : Mitochondrial Disease : 2014-05-29 |
Completed |
: Phase III Trial of Coenzyme Q10 in Mitochondrial Disease : Mitochondrial Diseases : 2007-02-06 :
|
Enrolling by invitation |
: Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Disease (PMD) : Primary Mitochondrial Disease : 2016-11-18 : Drug: elamipretide 40 mg, subcutaneous injections (in the abdomen) daily for the shortest of the followi |
Completed |
: Survey on Supplement Use in Mitochondrial Disease : Mitochondrial Disease : 2014-09-12 |
Active, not recruiting |
: Calf Muscle Strength in Mitochondrial Diseases : Mitochondrial Disease : 2016-02-03 : Other: MRI and muscle dynamometer |
Recruiting |
: The Effect of Arginine and Citrulline Supplementation on Endothelial Dysfunction in Mitochondrial Diseases : Mitochondrial Diseases : 2016-06-15 :
|
Terminated |
: RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease : Mitochondrial Diseases : 2003-05-07 : Drug: RG2133 (2',3',5'-tri-O-acetyluridine) |